請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/104636完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 馮嬿臻 | zh_TW |
| dc.contributor.advisor | Yen-Chen Anne Feng | en |
| dc.contributor.author | 陳怡靜 | zh_TW |
| dc.contributor.author | Yi-Jing Chen | en |
| dc.date.accessioned | 2026-08-28T16:50:45Z | - |
| dc.date.available | 2026-08-29 | - |
| dc.date.copyright | 2026-08-28 | - |
| dc.date.issued | 2026 | - |
| dc.date.submitted | 2026-07-27 00:00:00 | - |
| dc.identifier.citation | 1. Mullins, N., et al., Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. Nat Genet, 2021. 53(6): p. 817–829.
2. Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium. Electronic address, a.m.e.a.u. and C. Major Depressive Disorder Working Group of the Psychiatric Genomics, Trans-ancestry genome-wide study of depression identifies 697 associations implicating cell types and pharmacotherapies. Cell, 2025. 188(3): p. 640–652 e9. 3. Imran, A., et al., Psychological resilience and mood disorders: a systematic review and meta-analysis. Trends Psychiatry Psychother, 2024. 46: p. e20220524. 4. Hirschfeld, R.M., Differential diagnosis of bipolar disorder and major depressive disorder. J Affect Disord, 2014. 169 Suppl 1: p. S12–6. 5. Ministry of Health and Welfare, T., Statistical analysis of outpatient and inpatient care for psychiatric disorders. 2024. 6. Aldinger, F. and T.G. Schulze, Environmental factors, life events, and trauma in the course of bipolar disorder. Psychiatry Clin Neurosci, 2017. 71(1): p. 6–17. 7. He, Q., et al., Influence of polygenic risk scores for schizophrenia and resilience on the cognition of individuals at-risk for psychosis. Transl Psychiatry, 2021. 11(1): p. 518. 8. Otte, C., et al., Major depressive disorder. Nat Rev Dis Primers, 2016. 2: p. 16065. 9. Wu, G., et al., Understanding resilience. Front Behav Neurosci, 2013. 7: p. 10. 10. Nunes, K.G. and N.S. da Rocha, Resilience in severe mental disorders: correlations to clinical measures and quality of life in hospitalized patients with major depression, bipolar disorder, and schizophrenia. Qual Life Res, 2022. 31(2): p. 507–516. 11. Hess, J.L., et al., A polygenic resilience score moderates the genetic risk for schizophrenia. Mol Psychiatry, 2021. 26(3): p. 800–815. 12. Chan, M.K., Q.H. Chew, and K. Sim, Resilience in Bipolar Disorder and Interrelationships With Psychopathology, Clinical Features, Psychosocial Functioning, and Mediational Roles: A Systematic Review. J Clin Psychiatry, 2023. 84(2). 13. Connor, K.M. and J.R. Davidson, Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC). Depress Anxiety, 2003. 18(2): p. 76–82. 14. Wagnild, G., A review of the Resilience Scale. J Nurs Meas, 2009. 17(2): p. 105–13. 15. Friborg, O., et al., A new rating scale for adult resilience: what are the central protective resources behind healthy adjustment? Int J Methods Psychiatr Res, 2003. 12(2): p. 65–76. 16. Echezarraga, A., et al., The Resilience Questionnaire for Bipolar Disorder: Development and validation. Arch Psychiatr Nurs, 2017. 31(4): p. 376–385. 17. Hess, J.L., et al., A polygenic resilience score moderates the genetic risk for schizophrenia: Replication in 18,090 cases and 28,114 controls from the Psychiatric Genomics Consortium. Am J Med Genet B Neuropsychiatr Genet, 2024. 195(2): p. e32957. 18. O'Connell, K.S., et al., Genomics yields biological and phenotypic insights into bipolar disorder. Nature, 2025. 639(8056): p. 968–975. 19. Saveanu, R.V. and C.B. Nemeroff, Etiology of depression: genetic and environmental factors. Psychiatr Clin North Am, 2012. 35(1): p. 51–71. 20. Stahl, E.A., et al., Genome-wide association study identifies 30 loci associated with bipolar disorder. Nature Genetics, 2019. 51(5): p. 793–803. 21. Chen, C.H., et al., Population structure of Han Chinese in the modern Taiwanese population based on 10,000 participants in the Taiwan Biobank project. Hum Mol Genet, 2016. 25(24): p. 5321–5331. 22. Chen, C.Y., et al., Analysis across Taiwan Biobank, Biobank Japan, and UK Biobank identifies hundreds of novel loci for 36 quantitative traits. Cell Genom, 2023. 3(12): p. 100436. 23. Feng, Y.A., et al., Taiwan Biobank: A rich biomedical research database of the Taiwanese population. Cell Genom, 2022. 2(11): p. 100197. 24. Choi, S.W., T.S. Mak, and P.F. O'Reilly, Tutorial: a guide to performing polygenic risk score analyses. Nat Protoc, 2020. 15(9): p. 2759–2772. 25. Kachuri, L., et al., Principles and methods for transferring polygenic risk scores across global populations. Nat Rev Genet, 2024. 25(1): p. 8–25. 26. Truong, B., et al., Integrative polygenic risk score improves the prediction accuracy of complex traits and diseases. Cell Genom, 2024. 4(4): p. 100523. 27. Tielbeek, J.J., et al., Uncovering the genetic architecture of broad antisocial behavior through a genome-wide association study meta-analysis. Mol Psychiatry, 2022. 27(11): p. 4453–4463. 28. Sakaue, S., et al., A cross-population atlas of genetic associations for 220 human phenotypes. Nat Genet, 2021. 53(10): p. 1415–1424. 29. Lam, M., et al., Comparative genetic architectures of schizophrenia in East Asian and European populations. Nat Genet, 2019. 51(12): p. 1670–1678. 30. Jung, H., et al., Integration of risk factor polygenic risk score with disease polygenic risk score for disease prediction. Commun Biol, 2024. 7(1): p. 180. 31. Gui, Y., et al., Sex-specific genetic association between psychiatric disorders and cognition, behavior and brain imaging in children and adults. Transl Psychiatry, 2022. 12(1): p. 347. 32. Demontis, D., et al., Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains. Nat Genet, 2023. 55(2): p. 198–208. 33. Day, F.R., K.K. Ong, and J.R.B. Perry, Elucidating the genetic basis of social interaction and isolation. Nat Commun, 2018. 9(1): p. 2457. 34. Campos, A.I., et al., Understanding genetic risk factors for common side effects of antidepressant medications. Commun Med (Lond), 2021. 1: p. 45. 35. Baselmans, B.M.L., et al., Multivariate genome-wide analyses of the well-being spectrum. Nat Genet, 2019. 51(3): p. 445–451. 36. Wightman, D.P., et al., A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease. Nat Genet, 2021. 53(9): p. 1276–1282. 37. Stevelink, R., et al., GWAS meta-analysis of over 29,000 people with epilepsy identifies 26 risk loci and subtype-specific genetic architecture. Nature Genetics, 2023. 55(9): p. 1471–1482. 38. Savage, J.E., et al., Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence. Nat Genet, 2018. 50(7): p. 912–919. 39. Meyers, T.J., et al., Transcriptome-wide association study identifies novel candidate susceptibility genes for migraine. HGG Adv, 2023. 4(3): p. 100211. 40. Lee, J.J., et al., Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals. Nat Genet, 2018. 50(8): p. 1112–1121. 41. Zhou, W., et al., Global Biobank Meta-analysis Initiative: Powering genetic discovery across human disease. Cell Genom, 2022. 2(10): p. 100192. 42. Nam, K., J. Kim, and S. Lee, Genome-wide study on 72,298 individuals in Korean biobank data for 76 traits. Cell Genom, 2022. 2(10): p. 100189. 43. Miyazawa, K., et al., Cross-ancestry genome-wide analysis of atrial fibrillation unveils disease biology and enables cardioembolic risk prediction. Nat Genet, 2023. 55(2): p. 187–197. 44. Mishra, A., et al., Stroke genetics informs drug discovery and risk prediction across ancestries. Nature, 2022. 611(7934): p. 115–123. 45. Levin, M.G., et al., Genome-wide association and multi-trait analyses characterize the common genetic architecture of heart failure. Nat Commun, 2022. 13(1): p. 6914. 46. Jung, H.U., et al., Assessment of polygenic risk score performance in East Asian populations for ten common diseases. Commun Biol, 2025. 8(1): p. 374. 47. Hartiala, J.A., et al., Genome-wide analysis identifies novel susceptibility loci for myocardial infarction. Eur Heart J, 2021. 42(9): p. 919–933. 48. Aragam, K.G., et al., Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants. Nat Genet, 2022. 54(12): p. 1803–1815. 49. Zhou, W., et al., Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies. Nat Genet, 2018. 50(9): p. 1335–1341. 50. Suzuki, K., et al., Genetic drivers of heterogeneity in type 2 diabetes pathophysiology. Nature, 2024. 627(8003): p. 347–357. 51. Graham, S.E., et al., The power of genetic diversity in genome-wide association studies of lipids. Nature, 2021. 600(7890): p. 675–679. 52. Ghodsian, N., et al., Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease. Cell Rep Med, 2021. 2(11): p. 100437. 53. Zorina-Lichtenwalter, K., et al., Genetic risk shared across 24 chronic pain conditions: identification and characterization with genomic structural equation modeling. Pain, 2023. 164(10): p. 2239–2252. 54. Monti, R., et al., Evaluation of polygenic scoring methods in five biobanks shows larger variation between biobanks than methods and finds benefits of ensemble learning. Am J Hum Genet, 2024. 111(7): p. 1431–1447. 55. Jiang, L., et al., A generalized linear mixed model association tool for biobank-scale data. Nat Genet, 2021. 53(11): p. 1616–1621. 56. Prive, F., et al., Portability of 245 polygenic scores when derived from the UK Biobank and applied to 9 ancestry groups from the same cohort. Am J Hum Genet, 2022. 109(1): p. 12–23. 57. Liu, M., et al., Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use. Nat Genet, 2019. 51(2): p. 237–244. 58. Lai, D., et al., Evaluating risk for alcohol use disorder: Polygenic risk scores and family history. Alcohol Clin Exp Res, 2022. 46(3): p. 374–383. 59. Liu, Z., et al., Genetic architecture of the inflammatory bowel diseases across East Asian and European ancestries. Nat Genet, 2023. 55(5): p. 796–806. 60. Timmers, P.R., et al., Genomics of 1 million parent lifespans implicates novel pathways and common diseases and distinguishes survival chances. Elife, 2019. 8. 61. Deelen, J., et al., A meta-analysis of genome-wide association studies identifies multiple longevity genes. Nat Commun, 2019. 10(1): p. 3669. 62. Lambert, S.A., et al., The Polygenic Score Catalog as an open database for reproducibility and systematic evaluation. Nat Genet, 2021. 53(4): p. 420–425. 63. Sullivan, P.F., et al., Psychiatric Genomics: An Update and an Agenda. Am J Psychiatry, 2018. 175(1): p. 15–27. 64. Purcell, S., et al., PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet, 2007. 81(3): p. 559–75. 65. Bulik-Sullivan, B.K., et al., LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat Genet, 2015. 47(3): p. 291–5. 66. 1000 Genomes Project Consortium, et al., A global reference for human genetic variation. Nature, 2015. 526(7571): p. 68–74. 67. International HapMap, C., et al., Integrating common and rare genetic variation in diverse human populations. Nature, 2010. 467(7311): p. 52–8. 68. Ge, T., et al., Polygenic prediction via Bayesian regression and continuous shrinkage priors. Nat Commun, 2019. 10(1): p. 1776. 69. Bolstad, I., et al., The relationships between use of alcohol, tobacco and coffee in adolescence and mood disorders in adulthood. Acta Psychiatr Scand, 2022. 146(6): p. 594–603. 70. Muntaner, C., et al., Socioeconomic position and major mental disorders. Epidemiol Rev, 2004. 26: p. 53–62. 71. van der Eijk, Y. and J. Woh, Is secondhand smoke associated with mental health issues? A narrative review of the evidence and policy implications. Health Policy, 2023. 136: p. 104900. 72. Yang, Y.H., E.K. Yeh, and H.G. Hwu, Prevalences of Schizophrenia, Bipolar Disorder, and Depressive Disorders in Community between Taiwan and Other Countries. Taiwanese Journal of Psychiatry, 2012. 26(2): p. 77–87. 73. Baris, R.O., et al., Molecular and in silico analyses of SYN III gene variants in autism spectrum disorder. Ir J Med Sci, 2023. 192(6): p. 2887–2895. 74. Mbimba, T., et al., TRAPPC9: Novel insights into its trafficking and signaling pathways in health and disease (Review). Int J Mol Med, 2018. 42(6): p. 2991–2997. 75. Vick, P., et al., Identification of ZBTB26 as a Novel Risk Factor for Congenital Hypothyroidism. Genes (Basel), 2021. 12(12). 76. Sato, A., et al., Characterization of TEK receptor tyrosine kinase and its ligands, Angiopoietins, in human hematopoietic progenitor cells. Int Immunol, 1998. 10(8): p. 1217–27. 77. Hori, K. and M. Hoshino, Neuronal Migration and AUTS2 Syndrome. Brain Sci, 2017. 7(5). 78. Zhang, X., et al., Low expression of DAB2IP contributes to malignant development and poor prognosis in hepatocellular carcinoma. J Gastroenterol Hepatol, 2012. 27(6): p. 1117–25. 79. Zhou, B., et al., PRDM16 Suppresses MLL1r Leukemia via Intrinsic Histone Methyltransferase Activity. Mol Cell, 2016. 62(2): p. 222–236. 80. Werren, E.A., et al., Biallelic variants in CSMD1 are implicated in a neurodevelopmental disorder with intellectual disability and variable cortical malformations. Cell Death Dis, 2024. 15(5): p. 379. 81. Sisodiya, S.M., et al., Genetic enhancement of cognition in a kindred with cone-rod dystrophy due to RIMS1 mutation. J Med Genet, 2007. 44(6): p. 373–80. 82. Vujkovic, M., et al., Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis. Nat Genet, 2020. 52(7): p. 680–691. 83. Park, S., et al., Multivariate genomic analysis of 5 million people elucidates the genetic architecture of shared components of the metabolic syndrome. Nat Genet, 2024. 56(11): p. 2380–2391. 84. Turley, P., et al., Multi-trait analysis of genome-wide association summary statistics using MTAG. Nat Genet, 2018. 50(2): p. 229–237. 85. Goes, F.S., et al., Genome-wide association study of schizophrenia in Ashkenazi Jews. Am J Med Genet B Neuropsychiatr Genet, 2015. 168(8): p. 649–59. 86. Schumann, G., et al., Genome-wide association and genetic functional studies identify autism susceptibility candidate 2 gene (AUTS2) in the regulation of alcohol consumption. Proc Natl Acad Sci U S A, 2011. 108(17): p. 7119–24. 87. Jansen, P.R., et al., Genome-wide analysis of insomnia in 1,331,010 individuals identifies new risk loci and functional pathways. Nat Genet, 2019. 51(3): p. 394–403. 88. Howard, D.M., et al., Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat Neurosci, 2019. 22(3): p. 343–352. 89. Wu, C.S., et al., Validation of Self-reported Medical Condition in the Taiwan Biobank. J Epidemiol, 2025. 35(3): p. 141–146. 90. Grotzinger, A.D., et al., Genomic structural equation modelling provides insights into the multivariate genetic architecture of complex traits. Nat Hum Behav, 2019. 3(5): p. 513–525. | - |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/104636 | - |
| dc.description.abstract | 情緒障礙，包含雙相情緒障礙症 (BD) 與重鬱症 (MDD)，常伴隨慢性病程與自殺風險，構成沉重的全球疾病負擔，而這些疾患往往同時受到遺傳與非遺傳因素影響。過去研究多著重於疾病風險與病理機制，而對於具有高遺傳風險但未發病之韌性族群，其遺傳架構與相關因素在東亞族群較缺乏探討。本研究利用台灣人體生物資料庫 (TWB) 之基線資料，探討台灣族群中對BD與MDD之韌性相關遺傳及非遺傳因素。
本研究納入TWB共134,680名年紀為20至90歲之參與者 (包含Batch 1之21,692名與Batch 2之112,988名參與者)。首先，透過PRSmix+整合62種與情緒障礙及其遺傳相關性狀之多基因風險分數 (PRS)，以提升BD與MDD的遺傳風險分層能力。接著，本研究以整合後的PRS定義前10%為高遺傳風險族群，將「高風險但未罹病者」定義為韌性個體，「高風險且罹病者」作為非韌性個體。我們於Batch 2高風險族群基因資料中，排除已知疾病風險相關變異後，針對兩種疾患各自進行韌性之全基因體關聯分析 (GWAS)，以探索獨立於疾病風險之韌性遺傳訊號，並根據此結果，於Batch 1建立多基因韌性分數 (polygenic resilience score, PRSr)。此外，本研究亦進一步分析TWB自我呈報問卷中之社會經濟、生活型態、疾病共病等因素與韌性狀態之相關性。 研究結果顯示，相較於單一PRS，PRSmix+在兩種疾病中皆展現較佳的疾病風險分層能力，辨析出韌性個體。然而，在BD與MDD之韌性GWAS中，皆未發現達全基因體顯著水準之變異位點，僅部分達提示性顯著之變異位點可能與精神或代謝等性狀有關。此外，BD與MDD PRSr在Batch 1高風險族群中，皆未能顯著區分韌性與非韌性個體，顯示遺傳訊號的偵測可能仍受限於現有樣本數與方法。在非遺傳因素方面，已婚狀態、較高教育程度、較高個人收入與規律運動與較高韌性呈正相關；相反地，二手菸暴露、嚼檳榔經驗及多項身體疾病 (如神經系統疾病) 則與較低韌性相關。 本研究成功建立高多基因風險架構，探討台灣族群情緒障礙之韌性。雖然韌性GWAS發現有限且PRSr預測表現不佳，但結果顯示社經條件、生活型態與疾病共病等可調整之非遺傳因素與情緒障礙韌性顯著相關。未來若能結合更大規模之東亞或多族群GWAS以及縱貫性資料，將有助於更精確地定義韌性並釐清其與不同因子之潛在因果路徑。 | zh_TW |
| dc.description.abstract | Mood disorders, including bipolar disorder (BD) and major depressive disorder (MDD), are chronic psychiatric conditions associated with substantial disease burden and suicide risk. These conditions are shaped by a complex interplay of genetic and non-genetic factors. While prior research has predominantly focused on disease risk and pathological mechanisms, the genetic architecture and correlates of “resilience”—defined as individuals who remain unaffected despite carrying a high genetic liability—remain underexplored in East Asian populations. Utilizing baseline data from the Taiwan Biobank (TWB), this study aims to investigate the genetic and non-genetic factors associated with resilience to BD and MDD in the Taiwanese population.
This study included a total of 134,680 participants aged 20 to 90 (21,692 participants from TWB Batch 1 and 112,988 from Batch 2). We applied PRSmix+ to integrate 62 polygenic risk scores (PRSs) for mood disorders and genetically correlated traits to improve risk stratification for BD and MDD. Individuals in the top 10% of the integrated PRS distribution were defined as the high-genetic-risk group. Within this group, unaffected individuals were classified as resilient, whereas affected individuals were classified as non-resilient. To explore resilience-specific signals, we removed known disease-risk variants and performed a genome-wide association study (GWAS) of resilience within the Batch 2 high-risk group. Based on these GWAS summary statistics, polygenic resilience scores (PRSr) were constructed in Batch 1. Beyond genetic influences, we also analyzed the associations between resilience and socioeconomic, lifestyle, and medical comorbidity factors, using TWB questionnaires data. The results demonstrated that PRSmix+ consistently outperformed single disease PRSs in risk stratification and identifying resilient individuals for both disorders. However, no variant reached genome-wide significance in either resilience GWAS, although several suggestive loci were mapped to genes related to psychiatric or metabolic traits. Furthermore, the BD and MDD PRSr did not significantly distinguish resilient from diseased individuals the Batch 1 high-risk subgroup, suggesting limited power to detect genetic resilience signals. Regarding non-genetic factors, being married, higher educational, higher personal income, and engaging in regular exercise were positively associated with resilience, whereas secondhand smoke exposure, betel nut use, and medical comorbidities, particularly neurological diseases, were correlated with a lower odds of resilience. In conclusion, this study applied a high-polygenic-risk framework to explore resilience to mood disorders within the Taiwanese population. Although the genetic findings were limited, our results highlight the importance of considering both genetic liability and modifiable non-genetic factors in understanding resilience to mood disorders. Future studies would benefit from larger-scale East Asian or multi-ancestry GWAS cohorts to define resilience with enhanced discriminatory power, as well as longitudinal data to validate the causal pathways linking non-genetic correlates to resilience. | en |
| dc.description.provenance | Submitted by admin ntu (admin@lib.ntu.edu.tw) on 2026-08-28T16:50:45Z No. of bitstreams: 0 | en |
| dc.description.provenance | Made available in DSpace on 2026-08-28T16:50:45Z (GMT). No. of bitstreams: 0 | en |
| dc.description.tableofcontents | 口試委員會審定書 i
誌謝 ii 中文摘要 iii ABSTRACT v Contents viii LIST OF FIGURES x LIST OF TABLES xi Chapter 1 Introduction 1 1.1 Disease burden and genetic architecture of mood disorders 1 1.2 Non-genetic influences on mood disorders 2 1.3 Conceptualizing resilience and definition 3 1.4 Research gap and objectives 4 Chapter 2 Materials and Methods 6 2.1 Data source: Taiwan Biobank 6 2.2 Definition of BD and MDD 7 2.3 PRSmix+: Integrated Polygenic Risk Scores 8 2.4 Identification of resilient individuals and Genome-wide Association Study (GWAS) 9 2.5 Polygenic resilience score (PRSr) 12 2.6 Statistical analysis 12 2.6.1 Association between genetic variations, non-genetic factors and resilience status 12 2.6.2 Stratification analysis of polygenic resilience score (PRSr) 14 Chapter 3 Results 16 3.1 Descriptive statistics of Taiwan biobank 16 3.2 PRSmix+ outperformed single PRS in risk stratification 17 3.3 Resilience GWAS and resilience-associated SNPs 18 3.4 Identification of resilience status by polygenic resilience score 20 3.5 Association between non-genetic factors and resilience 21 3.6 Multivariable associations of genetic liability and non-genetic factors with resilience 24 3.7 Stratification by polygenic resilience score 25 Chapter 4 Discussion 27 REFERENCES 35 Figures 42 Tables 49 Appendix 52 | - |
| dc.language.iso | en | - |
| dc.subject | 情緒障礙 | - |
| dc.subject | 雙相情緒障礙症 | - |
| dc.subject | 重鬱症 | - |
| dc.subject | 韌性 | - |
| dc.subject | 多基因風險分數 | - |
| dc.subject | 台灣人體生物資料庫 | - |
| dc.subject | Mood disorder | - |
| dc.subject | Bipolar disorder | - |
| dc.subject | Major depressive disorder | - |
| dc.subject | Resilience | - |
| dc.subject | Polygenic risk score | - |
| dc.subject | Taiwan Biobank | - |
| dc.title | 台灣族群中情緒障礙之高遺傳易感但未發病者：遺傳與非遺傳相關因子之解析 | zh_TW |
| dc.title | Dissecting genetic and non-genetic correlates among those with high genetic liability to mood disorders yet unaffected in Taiwanese population | en |
| dc.type | Thesis | - |
| dc.date.schoolyear | 114-2 | - |
| dc.description.degree | 碩士 | - |
| dc.contributor.oralexamcommittee | 郭柏秀;張慶國;陳弘昕 | zh_TW |
| dc.contributor.oralexamcommittee | Po-Hsiu Kuo;Chin-Kuo Chang;Hung-Hsin Chen | en |
| dc.subject.keyword | 情緒障礙; 雙相情緒障礙症; 重鬱症; 韌性; 多基因風險分數; 台灣人體生物資料庫 | zh_TW |
| dc.subject.keyword | Mood disorder; Bipolar disorder; Major depressive disorder; Resilience; Polygenic risk score; Taiwan Biobank | en |
| dc.relation.page | 89 | - |
| dc.identifier.doi | 10.6342/NTU202602550 | - |
| dc.rights.note | 同意授權(限校園內公開) | - |
| dc.date.accepted | 2026-07-28 | - |
| dc.contributor.author-college | 公共衛生學院 | - |
| dc.contributor.author-dept | 健康數據拓析統計研究所 | - |
| dc.date.embargo-lift | 2026-08-29 | - |
| 顯示於系所單位： | 健康數據拓析統計研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-114-2.pdf 授權僅限NTU校內IP使用（校園外請利用VPN校外連線服務） | 3.21 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。